About

Our Story

Novuson, a spinout from the University of Washington’s highly regarded Applied Physics Laboratory’s Center for Industrial and Medical Ultrasound, is developing its Direct Therapeutic Ultrasound (DTU) technology platform for coagulation and hemostatic control in surgical and trauma procedures. DTU technology should enable clinicians to perform surgeries more quickly and to rapidly control bleeding associated with traumatic injuries. The company founder is Stuart B. Mitchell, PhD.

We at Novuson Surgical Embrace Our Core Values:

TEAM:  Our most valuable resource
RESPECT:  Honor the diversity and uniqueness of each individual
OPENNESS:  Everyone has a voice
DEDICATION:  We believe the devices we develop will improve surgical outcomes and save lives
QUALITY:  Our products are of the highest quality in feel and function
INTEGRITY:  Trust, honesty and doing the right thing is essential
INNOVATION:  We invent possibilities and turn them into useful, meaningful medical device solutions

Executive Team
Board of Directors
Medical Advisory Board

Stuart B. Mitchell, PhD

CEO, Founder and Chief Science Officer

Dr. Mitchell is a graduate of the University of Washington and he has been designing biomedical instrumentation and devices for approximately 20 years. Dr. Mitchell has extensive experience in biomechanics (soft tissue and orthopedic), tissue engineering, instrumentation, electronics, and mechanical design.

Read More

Jean Maixner, DVM

EVP Operations and Finance

Founder and Hospital Administrator Animal Critical Care and Emergency Services, 2 locations, 100+ employees, Exit via Acquisition with 7000% ROI.

Derek Khorsand, MD

Chief Medical Officer, NOVUSON Surgical Interventional Radiologist, Coeur d'Alene, Idaho

Derek grew up in a small town in southwest Washington and is a graduate of the University of Washington School of Medicine, where he was the top graduate in his class. After a year of training in general surgery, Derek trained in Interventional Radiology at the University of Washington, where he was Chief Resident. He has a strong background in basic and clinical research and experience in medical device commercialization.

Marco Daoura, MSBioE, SSGBC

Executive Vice President of Program and Product Management

Mr. Daoura graduated from the University of Washington with both a Bachelor of Science in Electrical Engineering and a Master of Science in BioEngineering with focus on Control Theory and Molecular Biotechnology. He has over 20 years in the healthcare industry from Philips Healthcare to Fujifilm Medical Systems, UltraLinq Healthcare. His work in innovation crosses many multidisciplinary areas from technology development, to technology architecture, program management, product services, product management and marketing, and market commercialization.

Read More

Carla Corkern

CEO and Chairman of the Board, Talyst

Ms. Corkern brings more than 20 years of experience in high-tech and supply chain management, and has helped build a number of highly-successful technology companies.
Dedicated to the mission of engineering the safer pharmacy, Carla Corkern brings a strategic mindset with high-tech and business savvy to the role of Talyst’s CEO and Chairman of the Board.

She champions the elimination of medication waste and medical errors that are so widespread and costly within the US healthcare system. She believes the primary objectives of health reform can be achieved with a focus on these principles, and she advocates for the adoption of proven technology to deliver vastly improved patient safety and cost savings.

Embracing the big picture, Ms. Corkern is focused on building long-term success by enabling the success of its customers. She strives to continuously uncover and cultivate new markets that would benefit from Talyst’s expertise and secure a pipeline of new business for the company.

Sam Liao

Sam Liao CFO, Series A Investor

Previously with Lakeside, Metropolitan Investments and Merrill Lynch Capital Investments. Mr. Liao brings financial and investment oversight to Novuson’s Board

James M. Kaiser

Director of Venture Capital at HOYA Corporation

James is a business executive with a pharmaceutical research background and a wide range of skills and experiences. He has worked in fortune 500 pharmaceutical corporations, academic institutions, small startup companies, non-profits, and the military.

Stuart B. Mitchell, PhD

CEO, Founder and Chief Science Officer

Dr. Mitchell is a graduate of the University of Washington and he has been designing biomedical instrumentation and devices for approximately 20 years. Dr. Mitchell has extensive experience in biomechanics (soft tissue and orthopedic), tissue engineering, instrumentation, electronics, and mechanical design.

Read More